Icad Inc (ICAD) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket
 


Icad Inc  (NASDAQ: ICAD)


Icad Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Icad Inc's ROI in the first quarter of 2025?
Icad Inc recorded a cumulative net loss of $-5 million during 12 months ending in the first quarter of 2025, resulting in a negative return on investment (ROI) of -16.76%.

Within the Healthcare sector 302 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2024 from 2944 to 3107.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM -8.45 % -6.92 % -5.96 % -7.44 % -13.67 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 32 30 31 32 34
Return On Investment (TTM) -16.76 % -17.66 % -8.21 % -6.72 % -6.73 %
ICAD's Overall Ranking # 3107 # 2944 # 2459 # 2513 # 2438
Seq. Investment Change TTM -1.93 % -3.56 % -2.8 % -0.41 % -0.29 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -5 -6 -3 -2 -2




Return On Investment ICAD's Ranking
Within: No.
Industry # 92
Sector # 303
Overall # 3107

Return On Investment Statistics
High Average Low
-1.69 %
-40.19 %
-95.16 %
(Dec. 30, 2014)   (March 31, 2016)



  News about Icad Inc Return on Investment ROI

iCAD Expands Sales Leadership Team and Adds Key Executives to Accelerate Growth Amidst New Products and Partnerships

December 18, 2023



As iCAD Inc, a leading healthcare technology company, continues to expand its business and enhance its product offerings, it has made important additions to its executive sales leadership team. Bill Keyes, an existing member of the team, has transitioned to the role of Senior Vice President, Global Sales Operations. Additionally, Peter Graham has joined iCAD as the new Senior Vice President, North American Sales. These strategic appointments aim to accelerate the company s growth and further establish its presence in the healthcare sector.
Expansion of Roles:
Bill Keyes, previously serving in a different capacity within the executive sales leadership team, has assumed the crucial role of Senior Vice President, Global Sales Operations. In this newly expanded position, Keyes will play a key role in overseeing iCAD s sales operations on a global scale. With his extensive experience and deep understanding of the company s operations, Keyes is expected to contribute significantly to iCAD s growth strategy.






Financial Statements
Icad Inc's I. Quarter Investments $ 32 Millions ICAD's Balance sheet
Icad Inc's I. Quarter Income $ -1 Millions Quarterly ICAD's Income Statement
ICAD's Income by Division See ICAD's Income by Division


ICAD Annual Return On Investment (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
Total Investments in Millions 30 35 38 47 39
Y / Y Investment Growth -13.53 % -9.37 % -19.01 % 21.63 % 318.89 %
Net Income in Millions -6 -5 -14 -11 -18
Y / Y Net Income Growth - - - - -
Annual Return On Investment -18.73 % -13.98 % -35.7 % -23.81 % -45.35 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ICAD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ICAD's Competitors
Subscribers only: Roi for Icad Inc's Suppliers
Subscribers only: Return On Investment for ICAD's Customers

Other Ratios
ICAD's Roa ICAD's Inventory Turnover Ratio ICAD's Growth Rates ICAD's Dividend Statistics
ICAD's Profitability Ratios ICAD's Asset Turnover Ratio ICAD's Dividend Growth
ICAD's Roe ICAD's Valuation Ratios ICAD's Financial Strength Ratios ICAD's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI


Date modified: 2026-09-12T06:14:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.